NCT04601298View on ClinicalTrials.gov

The Risk Stratification of Papillary Thyroid Cancer With AUS/FLUS by FNA

CompletedOBSERVATIONAL
Enrollment

290

Participants

Timeline

Start Date

August 1, 2015

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Thyroid CancerAtypia of Undetermined SignificanceFLUS
Interventions
OTHER

Trial Locations (1)

200072

Shanghai 10Th People'S Hospital, Shanghai

All Listed Sponsors
lead

Shanghai 10th People's Hospital

OTHER

NCT04601298 - The Risk Stratification of Papillary Thyroid Cancer With AUS/FLUS by FNA | Biotech Hunter | Biotech Hunter